Dr. Reddy's Laboratories Limited (BOM: 500124)
6,611.10
-40.75 (-0.61%)
At close: Sep 11, 2024
Dr. Reddy's Laboratories Revenue
Dr. Reddy's Laboratories had revenue of 76.73B INR in the quarter ending June 30, 2024, with 13.87% growth. This brings the company's revenue in the last twelve months to 288.51B, up 10.49% year-over-year. In the fiscal year ending March 31, 2024, Dr. Reddy's Laboratories had annual revenue of 279.16B with 13.54% growth.
Revenue (ttm)
288.51B
Revenue Growth
+10.49%
P/S Ratio
3.84
Revenue / Employee
10.67M
Employees
27,048
Market Cap
1,108.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 279.16B | 33.29B | 13.54% |
Mar 31, 2023 | 245.88B | 31.49B | 14.69% |
Mar 31, 2022 | 214.39B | 24.67B | 13.00% |
Mar 31, 2021 | 189.72B | 15.12B | 8.66% |
Mar 31, 2020 | 174.60B | 20.75B | 13.49% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDr. Reddy's Laboratories News
- 1 day ago - Dr. Reddy’s refutes Congress allegations over engagement with Dhaval Buch’s Agora Advisory - Business Upturn
- 5 days ago - Dr. Reddy’s Laboratories receives USFDA EIR for Srikakulam API facility inspection - Business Upturn
- 8 days ago - Dr. Reddy's Stock Hit All-Time High Last Month. Ready To Climb Again? - Investor's Business Daily
- 13 days ago - Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry - Benzinga
- 13 days ago - Dr. Reddy's Strategic Vision Reiterated Following Strong Q1FY25 Results - IBTimes
- 14 days ago - Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry - Benzinga
- 21 days ago - Dr. Reddy's Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug - Business Wire
- 4 weeks ago - In-Depth Analysis: Merck & Co Versus Competitors In Pharmaceuticals Industry - Benzinga